Core Viewpoint - The integration of AI technology in elderly care is transforming the landscape of healthcare in Hong Kong, making "smart aging" a reality and injecting new vitality into the medical technology industry [1][4]. Group 1: AI Empowerment in Elderly Care - The 16th Hong Kong International Medical and Healthcare Exhibition showcased around 300 exhibitors from 13 countries, presenting innovative AI-powered products for elderly care, such as AI rehabilitation systems and portable AI diagnostic tools [1][2]. - The elderly population in Hong Kong is projected to reach 23.9% by 2024, highlighting the urgent need for technology to support and enhance the quality of life for seniors [1][4]. Group 2: Innovative Products and Technologies - A wearable exoskeleton robot designed based on the principle of neural plasticity allows individuals with severe mobility impairments to regain the ability to walk through AI-driven gait training [2]. - AI-driven solutions include a VR eye-tracking device for cognitive impairment assessment, a smart mattress that monitors pressure distribution to predict bedsores, and a portable detection device for non-invasive health checks [3][4]. Group 3: Future of Elderly Care - The Hong Kong government anticipates that by 2043, seniors aged 65 and above will constitute over one-third of the population, necessitating advancements in elder care technology [4]. - Innovations such as smart nursing beds equipped with sensors to monitor vital signs and assist with patient mobility are being developed to enhance the dignity and care of the elderly [4][5].

Group 1 - The 2025 Shanghai Technology Festival opened in Zhangjiang, Shanghai, showcasing robots from Fourier, a company specializing in robotics [1] - The two featured robots, Fourier N1 and GR-2, attracted significant attention, highlighting the company's advancements in robotics technology [1][3] - Fourier N1 is a compact robot with a height of 1.3 meters and a weight of 38 kilograms, capable of running at a speed of 3.5 meters per second and has completed over 1000 hours of outdoor testing [3] Group 2 - Fourier GR-2 is a larger robot, standing at 1.75 meters and weighing 63 kilograms, equipped with advanced actuators and a self-developed dexterous hand, enabling versatile applications in various fields [3] - The company has been active in the medical robotics sector for ten years, with products deployed in over 3000 medical terminals globally [3][4] - Fourier has developed over 30 rehabilitation robot products, delivering thousands of units, and aims to expand the use of humanoid robots in rehabilitation hospitals and community health service centers in the next few years [4] Group 3 - The rehabilitation robots possess significant commercial and social value, with a large market potential, but they require advanced technology for effective human interaction [4] - The integration of the robot's "brain" and "cerebellum" is a current challenge, affecting real-time and rapid action generation [4] - The company is focused on building a robust industrial ecosystem through collaborations with hospitals, universities, and research institutions to shorten innovation cycles [5]

Core Viewpoint - Fourier has established a "humanoid + rehabilitation" concept application scene in collaboration with Shanghai International Medical Center, focusing on the integration of humanoid robots in rehabilitation therapy and medical services [1][2]. Group 1: Company Overview - Founded in 2015, Fourier initially entered the market with medical rehabilitation robots and launched China's first commercial lower limb exoskeleton robot in 2017, gradually forming a comprehensive product matrix covering upper limbs, lower limbs, and balance training [1][3]. - Fourier has introduced over 30 intelligent rehabilitation products and provides professional services to more than 3,000 medical institutions across over 60 countries and regions [1][7]. Group 2: Product and Technology Development - The company has developed various intelligent rehabilitation devices, including lower limb exoskeleton robots and three-dimensional upper limb rehabilitation robots, which enhance treatment efficiency and reduce the need for multiple therapists [2][3]. - Fourier's humanoid robots, such as the GR-1 and GR-2, are designed for applications in guidance, consultation, and academic research, showcasing the versatility of humanoid robots in medical settings [3][4]. Group 3: Strategic Focus and Future Plans - The CEO of Fourier emphasized a core strategy for the next decade focused on human-centered embodied intelligence, aiming to enhance interaction, efficiency, and research innovation in rehabilitation and elder care [3][4][5]. - Fourier plans to optimize strategies around embodied intelligence to improve the efficiency of rehabilitation therapists, allowing them to manage multiple robots simultaneously [6][8]. Group 4: Industry Context and Challenges - The company recognizes the shortage of experienced rehabilitation therapists in China, particularly in rural areas, and aims to address this gap through the deployment of humanoid robots [6][7]. - The broader industry faces challenges in the implementation of embodied intelligence technology in healthcare, including ecological, talent, and policy barriers [10][11]. Group 5: Collaborative Efforts and Initiatives - Fourier has initiated collaborations with institutions like Tongji University and launched the "Embodied Intelligent Rehabilitation Technology Development Initiative" to accelerate clinical applications of embodied intelligence [10][11]. - The company is also involved in government initiatives aimed at promoting technological innovation in elder care and medical robotics, with a goal to establish Shanghai as a hub for medical robot technology by 2025 [12].

Core Viewpoint - The article discusses the evolution and future prospects of Fourier, a company specializing in humanoid robots, particularly in the context of healthcare and rehabilitation, highlighting its journey from inception to becoming a key player in the field of embodied intelligence [3][5][6]. Company Development - Fourier was founded ten years ago, initially focusing on rehabilitation robots and later expanding into humanoid robots, with the first prototype being developed in 2022 [3][5]. - The company has launched several humanoid robots, including GR-1 and GR-2, and plans to release more products by the end of the year [5][6]. Market Environment - The market for humanoid robots faced skepticism in the past, with many investors viewing them as mere toys; however, recent advancements in large model technology have transformed the perception of embodied intelligence into a new growth area [4][6]. - The healthcare sector is seen as a critical application area for humanoid robots, with Fourier's existing presence in over 3,000 medical institutions providing a strong foundation for future developments [6][10]. Technological Advantages - Fourier's expertise in core components from rehabilitation robots is leveraged in humanoid robot development, maintaining a focus on dual-legged designs [6][10]. - The company emphasizes the importance of interactivity and human-centric design in both industrial and healthcare applications, aiming to enhance robots' perception and decision-making capabilities [7][10]. Future Applications - Humanoid robots are expected to play significant roles in rehabilitation, elderly care, and companionship, with a focus on interactive and cognitive training [8][10]. - The timeline for bringing a medical-grade humanoid robot from concept to market is estimated to be three to four years, considering the necessary validation and regulatory processes [9][10]. Competitive Differentiation - Fourier differentiates itself through its technological advancements, including force feedback technology and AI-driven motion capabilities, which allow for adaptive interactions with users [10][12]. - The company has accumulated a wealth of rehabilitation data, enabling it to understand user needs and refine its robots' functionalities [10][12]. Collaboration and Ecosystem - Fourier recognizes the need for collaboration within the industry, particularly in sensor technology and AI model development, to enhance the capabilities of humanoid robots [12][13]. - The company aims to build partnerships with AI firms to leverage existing infrastructures and adapt models for specific applications [13][15]. Market Strategy - Fourier intends to maintain its focus on the B2B market while exploring potential C2C opportunities as technology evolves, emphasizing the importance of efficiency and user empowerment [15][16]. - The company views its rehabilitation and humanoid robot segments as interconnected, with plans for diverse robot forms to meet various user needs [16].

Core Viewpoint - Fourier has evolved from a rehabilitation robotics company to a general humanoid robotics company, marking its tenth anniversary with significant advancements in humanoid robot development, including the launch of GR-1 and GR-2 [1][2][3] Company Development - Founded ten years ago in Zhangjiang, Fourier initially focused on rehabilitation robots, becoming one of the first teams in China to commercialize exoskeleton robots for medical rehabilitation [1][2] - The first humanoid robot prototype was developed in 2022, with the official launch of GR-1 in July 2023 at the World Artificial Intelligence Conference [2][3] Market Environment - The humanoid robotics market faced skepticism from investors initially, with many viewing humanoid robots as mere toys [2] - The landscape has changed, with advancements in large model technology driving interest and investment in embodied intelligence as a new frontier [2][3] Technological Focus - Fourier's strategy emphasizes the integration of core components from rehabilitation robots into humanoid robots, maintaining a bipedal design and achieving mass production of bipedal humanoid robots in 2023 [3][7] - The company has accumulated extensive data and experience from over 3,000 medical institutions, enhancing its understanding of user needs [3][7] Future Applications - Humanoid robots are expected to play significant roles in rehabilitation, elderly care, and companionship, with a focus on interaction, perception, and decision-making capabilities [5][8] - The company envisions a range of applications in the medical field, from patient guidance to night ward companionship, and extending into community and home settings [8][9] Product Development Timeline - The development timeline for a medical-grade humanoid robot from concept to market is approximately three to four years, including prototype validation and regulatory approval [6][12] Competitive Advantage - Fourier's competitive edge lies in its early focus on force feedback technology, advanced algorithms for motion capabilities, and a deep understanding of human-robot interaction [7][10] - The company aims to collaborate with partners for sensor development and leverage existing AI infrastructure to enhance its robotic capabilities [9][10] Market Strategy - While currently focused on B2B applications, Fourier is open to exploring C2C opportunities as technology evolves, although no immediate plans for C2C products exist [11][12] - The company does not view its rehabilitation and humanoid robotics segments as separate but rather as interconnected within the broader field of embodied intelligence [12][13]